Trenten Prioleau, DPM
Podiatrist · Columbia, SCNPI 1104129790
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Paratek Pharmaceuticals, Inc. at 25.4% of the total. Reporting peaked in 2023 at $195 and has fallen 67.3% since, to $64 in 2025. That places this record below the midpoint for podiatrist clinicians in SC, where the typical reported total is $1,261.
Across 18 payments — averaging $24.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$112
- Averitas Pharma Inc.$76
- Amgen$59
- Vital Connect, Inc$50
- Kerecis Limited$49
- Smith+Nephew$41
- plus $53 from 3 others
What the payments were for
- Food & beverage$439100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 5 | $112 |
| Averitas Pharma Inc. | 3 | $76 |
| Amgen | 3 | $59 |
| Vital Connect, Inc | 1 | $50 |
| Kerecis Limited | 1 | $49 |
| Smith+Nephew | 2 | $41 |
| Convatec Inc. | 1 | $24 |
| Pfizer | 1 | $16 |
| Trice Medical, Inc. | 1 | $13 |
How this compares
$439 in reported general payments places this provider in the 35th percentile of 61 podiatrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 18 | $61,978 |
| Ammonium Lactate | 141 | $1,411 |
| Clotrimazole | 44 | $1,145 |
| Gabapentin | 68 | $878 |
| Ketoconazole | 48 | $674 |
| Ciclopirox | 22 | $609 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 30 | $580 |
| Diclofenac Sodium | 20 | $546 |
| Terbinafine Hcl | 37 | $379 |
| Cephalexin | 20 | $268 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Columbia
- Harold CookColumbia$3K
- Bridget MooreColumbia$2K
- Daniel MillerColumbia$1K
- Byron JacksonColumbia$156
- Robert ChristianColumbia$79
- Keshia OliverColumbia$68
- Cruddie TorianColumbia$28
- Brandon PercivalLancaster$136K
- Alan BlockFlorence$96K
- William LongSimpsonville$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.